美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63402-193-03	63402-193	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20181101	20250731	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	3 mg/1	30 TABLET, COATED in 1 BOTTLE (63402-193-03)
63402-191-03	63402-191	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20181101	20250131	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	2 mg/1	30 TABLET, COATED in 1 BOTTLE (63402-191-03)
63402-190-30	63402-190	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20080527	20250731	NDA	NDA021476	Sumitomo Pharma America, Inc.	ESZOPICLONE	1 mg/1	30 TABLET, COATED in 1 BOTTLE (63402-190-30)
80725-010-30	80725-010	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20230815	N/A	NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	1 mg/1	30 TABLET, COATED in 1 BOTTLE (80725-010-30)
80725-011-30	80725-011	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20230815	N/A	NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	2 mg/1	30 TABLET, COATED in 1 BOTTLE (80725-011-30)
80725-012-30	80725-012	HUMAN PRESCRIPTION DRUG	Lunesta	ESZOPICLONE	TABLET, COATED	ORAL	20230815	N/A	NDA	NDA021476	Waylis Therapeutics LLC	ESZOPICLONE	3 mg/1	30 TABLET, COATED in 1 BOTTLE (80725-012-30)